UK Begins Human Trials of New Ebola Vaccine in Just 57 Days as Scientists Race to Stop Deadly Virus
Oxford University has initiated human trials for a new Ebola vaccine just 57 days after development, targeting the Bundibugyo strain amid an outbreak in the Congo and Uganda.
International Business Times UK ·